GlassScriptPhysician profile
Mary P Van Hal
NPI 1902976442
$6,970.14
in general payments reported to CMS, 2019-2025
55 companies · $1,072 in 2025
The $1,072 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $734 · 2020: $702 · 2021: $797 · 2022: $969 · 2023: $1,341 · 2024: $1,356 · 2025: $1,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,668 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,667.94 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $819.23 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $796.22 | 2019-2025 | |
| Lilly USA, LLC | $670.58 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $606.95 | 2019-2025 | Jardiance |
| Abbvie INC. | $440.23 | 2019-2025 | Ubrelvy, Linzess |
| Astrazeneca Pharmaceuticals LP | $396.72 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $378.51 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Astellas Pharma US INC | $256.72 | 2021-2025 | Veozah, Myrbetriq |
| Amgen INC. | $219.76 | 2019-2025 | Repatha, Evenity, Otezla |
| Allergan, INC. | $192.17 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $177.86 | 2019-2025 | Xarelto, Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $164.41 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $99.03 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $91.08 | 2020-2025 | Gardasil 9, Capvaxive, Gardasil |
| Antares Pharma, INC. | $90.64 | 2022-2023 | Nocdurna, Xyosted, Tlando |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $83.38 | 2022-2023 | Qelbree, Xyosted |
| Abbott Laboratories | $81.98 | 2021-2025 | Freestyle Libre 3 |
| Genentech USA, INC. | $81.05 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $76.13 | 2020-2023 | |
| Alnylam Pharmaceuticals INC. | $75.66 | 2021-2024 | Oxlumo, Givlaari |
| Kowa Pharmaceuticals America, INC. | $71.03 | 2020-2024 | Livalo, Seglentis |
| Exact Sciences Corporation | $65.04 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Inspire Medical Systems, INC. | $61.90 | 2023-2025 | Inspire |
| Teva Pharmaceuticals USA, INC. | $57.19 | 2019-2022 | |
| Medtronic, INC. | $56.11 | 2023-2024 | Venaseal, Intellis Adaptivestim |
| Alexion Pharmaceuticals, INC. | $55.05 | 2023 | Strensiq |
| Phathom Pharmaceuticals, INC. | $52.29 | 2024-2025 | Voquezna |
| Dynavax Technologies Corporation | $51.74 | 2024-2025 | Heplisav-B |
| Genzyme Corporation | $49.56 | 2022 | |
| Bausch Health US, LLC | $45.95 | 2021-2023 | Aplenzin |
| Renalytix Ai, INC. | $45.69 | 2023-2024 | Kidneyintelx Blood Collection Convenience Kit |
| Aurinia Pharma U.S., INC. | $38.95 | 2022 | |
| Dexcom, INC. | $38.72 | 2023-2025 | Dexcom G6 Transmitter |
| Jazz Pharmaceuticals INC. | $32.51 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $32.04 | 2023 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $31.62 | 2022 | |
| Arbor Pharmaceuticals, INC. | $31.53 | 2020-2021 | |
| Amarin Pharma, INC. | $28.63 | 2019 | |
| Scilex Pharmaceuticals INC. | $26.94 | 2022 | |
| Sanofi-Aventis U.S. LLC | $23.78 | 2020 | |
| Verity Pharmaceuticals INC. | $22.31 | 2024 | Tlando |
| Acella Pharmaceuticals, LLC | $21.76 | 2025 | NP Thyroid 60 |
| Almatica Pharma LLC | $21.44 | 2024 | Loreev Xr |
| Sanofi Pasteur INC. | $20.51 | 2023 | |
| Sumitomo Pharma America, INC. | $20.38 | 2024 | Gemtesa |
| Halozyme INC | $20.15 | 2023 | |
| Bioventus LLC | $20.13 | 2019 | |
| Mannkind Corporation | $18.76 | 2022 | |
| Corcept Therapeutics | $18.28 | 2025 | Korlym |
| Phadia US INC. | $17.40 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.55 | 2021 | |
| Eisai INC. | $16.09 | 2021 | |
| Ibsa Pharma INC. | $14.59 | 2025 | Tirosint, Licart, Flector |
| Intuitive Surgical, INC. | $13.63 | 2022 | |
| Xeris Pharmaceuticals, INC. | $13.58 | 2025 | Keveyis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Van Hal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.